{
    "clinical_study": {
        "@rank": "43457", 
        "acronym": "START", 
        "arm_group": [
            {
                "arm_group_label": "Smoking Termination and Anxiety Reduction Treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "Cognitive-behavioral treatment program that blends smoking cessation and anxiety reduction treatment strategies"
            }, 
            {
                "arm_group_label": "Educational-Support Psychotherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Educational-based psychotherapy and standard smoking cessation treatment program"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary aim of this research study is to enhance smoking cessation outcome among smokers\n      with anxiety disorders. We are comparing two group treatment approaches: (1) An\n      educational-supportive psychotherapy and standard smoking cessation treatment, and (2) An\n      integrated smoking cessation and anxiety treatment program (START). Both treatments also\n      utilize nicotine replacement therapy."
        }, 
        "brief_title": "Smoking Termination / Anxiety Reduction Treatment (ST/ART)", 
        "condition": [
            "Smoking", 
            "Anxiety Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anxiety Disorders", 
                "Smoking"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ages 18-65 years old\n\n          -  Capable of providing informed consent\n\n          -  Willing to attend all study visits and comply with the protocol\n\n          -  Daily smoker for at least one year\n\n          -  Currently smoke an average of at least 6 cigarettes per day\n\n          -  Report a motivation to quit smoking in the next 6 weeks of at least 5 on a 10-point\n             scale\n\n        Exclusion Criteria:\n\n          -  Use of other tobacco products\n\n          -  Current or past psychotic disorders of any type, or comorbid psychiatric conditions\n             that are relative or absolute contraindications to the use of any treatment option in\n             the study protocol\n\n          -  Currently suicidal or high suicide risk\n\n          -  Current use of any pharmacotherapy or psychotherapy for smoking cessation not\n             provided by the researchers during the quit attempt\n\n          -  Unwilling to cease use of benzodiazepines or other fast-acting anxiolytics\n\n          -  Concurrent psychotherapy initiated in the past three months, or ongoing anxiety\n             psychotherapy\n\n          -  Current or intended participation in a concurrent substance abuse treatment\n\n          -  Insufficient command of English to participate in assessment or treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01789125", 
            "org_study_id": "1R34DA03131301A1", 
            "secondary_id": "R34DA031313"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Smoking Termination and Anxiety Reduction Treatment", 
                    "Educational-Support Psychotherapy"
                ], 
                "intervention_name": "Nicotine Patch", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Smoking Termination and Anxiety Reduction Treatment", 
                "description": "Integrated smoking cessation and anxiety reduction treatment", 
                "intervention_name": "Smoking Termination and Anxiety Reduction Treatment", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Educational-Support Psychotherapy", 
                "intervention_name": "Education-Supportive Psychotherapy", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Nicotine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "anxiety", 
            "stress", 
            "smoking", 
            "cessation"
        ], 
        "lastchanged_date": "May 8, 2014", 
        "link": {
            "description": "Project Website", 
            "url": "http://uh.edu/ahrl-sutc"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77204"
                }, 
                "name": "Anxiety and Health Research Laboratory and Substance Use Treatment Clinic, University of Houston"
            }, 
            "investigator": {
                "last_name": "Michael J Zvolensky, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Augmenting Smoking Cessation With Transdiagnostic CBT for Smokers With Anxiety", 
        "overall_contact": {
            "email": "zrobles@uh.edu", 
            "last_name": "Zuzuky Robles, BA", 
            "phone": "713-743-8444"
        }, 
        "overall_official": [
            {
                "affiliation": "University of Houston", 
                "last_name": "Michael J Zvolensky, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Houston", 
                "last_name": "Peter Norton, Ph.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Smoking status", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline at 1, 2, 4, 8, 10, 16, and 24 weeks post quit day."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01789125"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Houston", 
            "investigator_full_name": "Michael J. Zvolensky, Ph.D.", 
            "investigator_title": "Hugh Roy and Lillie Cranz Cullen Distinguished University Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Houston", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of Houston", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}